Regarding trial NCT06122870 my opinion only.
The trial outcome will give a very early indication of the compounds efficacy 9very small cohort), I may be wrong but for my memory the only early data received re. efficacy against Campylobacter was via western blot analysis back in early 2017.
So the short answer is no, I don't believe the Campylobacter trial outcomes would cause the curtains to come down on the DoD collaborations. But thanks for the question , happy to hear others opinions.
Ann: Travelan to progress to Phase 3 Clinical Trials in the US, page-193
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.004(4.17%) |
Mkt cap ! $22.79M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $60.59K | 585.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1100 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 223780 | 4 |
View Market Depth
| Last trade - 15.35pm 30/07/2024 (20 minute delay) ? |
| IMC (ASX) Chart |